Aristotle Capital Boston LLC Has $12.36 Million Stock Position in Dolby Laboratories $DLB

Aristotle Capital Boston LLC lifted its position in shares of Dolby Laboratories (NYSE:DLBFree Report) by 12.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 192,483 shares of the electronics maker’s stock after buying an additional 21,125 shares during the quarter. Aristotle Capital Boston LLC’s holdings in Dolby Laboratories were worth $12,361,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Rothschild Investment LLC lifted its holdings in shares of Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after buying an additional 607 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after buying an additional 192 shares in the last quarter. Optiver Holding B.V. lifted its holdings in shares of Dolby Laboratories by 7,955.6% during the third quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock worth $52,000 after buying an additional 716 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in shares of Dolby Laboratories during the third quarter worth $56,000. Finally, iSAM Funds UK Ltd acquired a new stake in shares of Dolby Laboratories during the third quarter worth $68,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Trading Down 3.1%

Shares of NYSE DLB opened at $51.19 on Thursday. The company has a market cap of $4.84 billion, a price-to-earnings ratio of 20.23 and a beta of 0.81. Dolby Laboratories has a 12 month low of $51.08 and a 12 month high of $77.00. The stock has a 50-day moving average price of $57.83 and a two-hundred day moving average price of $61.86.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.8%. Dolby Laboratories’s payout ratio is presently 56.92%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DLB. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Thursday, June 11th. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research report on Monday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Dolby Laboratories has an average rating of “Moderate Buy” and an average price target of $90.75.

Get Our Latest Stock Report on Dolby Laboratories

Insiders Place Their Bets

In other Dolby Laboratories news, CMO Todd Pendleton sold 11,876 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total transaction of $647,835.80. Following the completion of the transaction, the chief marketing officer owned 41,480 shares of the company’s stock, valued at approximately $2,262,734. The trade was a 22.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John D. Couling sold 7,666 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $55.62, for a total value of $426,382.92. Following the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $6,603,595.74. The trade was a 6.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 39,791 shares of company stock worth $2,231,653 in the last ninety days. Insiders own 37.93% of the company’s stock.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.